3 unknown. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 3 | 2 | Unknown 2 |
Follow TIA: new trials by email Literature Review of TIA trials Research Report on TIA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) Ferrous succinate - Vascular Cognitive Impairment, Dementia, Vascular | Phase 2 | Unknown | Beijing Tiantan Hospital | 1006 | 2019-04-01 | 2020-07-13 |
| Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events Apixaban, Clopidogrel, Aspirin - Ischemic Stroke, TIA | Phase 2 / Phase 3 | Unknown | Xijing Hospital | 10000 | 2014-01-01 | 2013-08-16 |
| Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events rivaroxaban, Aspirin, placebo - Ischemic Stroke, TIA | Phase 2 / Phase 3 | Unknown | Xijing Hospital | 3700 | 2013-09-01 | 2013-08-16 |
Ischemic Stroke (2) · Anemia, Iron-Deficiency (1) · Cerebral Infarction (1) · Dementia (1) · Dementia, Vascular (1) · Iron Deficiencies (1)
Brain Diseases (3) · Cardiovascular Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Nervous System Diseases (3) · Stroke (3) · Vascular Diseases (3) · Anemia (1) · Anemia, Hypochromic (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Brain Infarction (1) · Brain Ischemia (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1)
Aspirin (2) · Clopidogrel (1) · Rivaroxaban (1) · apixaban (1) · ferrous succinate (1)
Xijing Hospital (2) · Beijing Tiantan Hospital (1)
China (3)
Gang Zhao, M.D. (2) · Jia Qian, doctor (1)